Overseas cannabis market

Thailand has adjusted the rules to allow this plant to be used legally. This is in line with many countries such as the US and Canada. People are consuming from markets where there are legal products. It has quality and safety, which adds more industrial value. From market data (Legal), In the US, Morning Star is estimated to be worth more than 300 billion baht in 2020 and is expected to increase to 2.5 trillion baht or more than eight times in 10 years or by 2030. It includes the value of recreational marijuana, also known as recreational. This may contain details of licensing laws that vary from state to state.

Investment through mutual funds

As a result, cannabis-related businesses are starting to gain more and more attention. In Thailand, it has begun to see some products related to this plant. This interest is beginning to resonate in terms of investment as well. The number of CBD kaufen funds around the world began to increase during 2017-2019.

Currently, there is a cannabis-hemp-related fund for Thai investors to choose to invest in, namely the MFC Global Cannabis Fund (MCANN) from MFC Asset Management. This fund will invest in the leading US ETFs. 2 stacks are

1) Amplify Seymour Cannabis ETF (CNBS) with an actively managed investment policy in companies with at least 50% revenue on cannabis and hemp in the fields of medicine, agriculture, and promotion, such as investment finance. As of May 14, 2021, the portfolio invested in 33 stocks with a turnover ratio of 94%.

2) The Global X Cannabis ETF (POTX) is passive management that delivers performance aligned with the Solactive Cannabis Index, which includes cannabis and hemp businesses such as cultivation, extract products, pharmaceutical production, and related financial services. Overall, it’s pretty much in the same direction as CNBS, with its portfolio as of May 14, 2021, invested in 25 stocks with a turnover ratio of around 60%.

Another fund is a fund from Asset Management Co., Ltd. V is We Cannabis Business (WE-CANAB), which also invests 40% in the Global X Cannabis ETF (POTX), and the remaining 60% is invested in passive investment ETFMB Alternative Harvest ETF (MJ). Together, to bring returns similar to the Prime Alternative Harvest Index, this index invests in medicinal or recreational cannabis. Including tobacco products Portfolio on May 17, 2021, invests in 30 stocks, turnover ratio of 46%.

Investing in CBD kaufen – hemp is new for many investors. Before starting to invest, it is essential to study and understand in detail, for example, what business does the fund invest in this plant’s supply chain? Which may bring different values and amending laws that will directly affect the production and distribution of cannabis. As for the risk in this type of fund, it is highly concentrated in the industry. Therefore, it may be riskier than stock funds diversified into several businesses at certain times.

From the example of funds that invest exclusively in cannabis around the world. It was found that there was a cumulative average return of the first four months of 30.8% (as of April 30, 2021), but if you look back on the pre-COVID period or the year 2019, the global return on investment is considered relatively high. But CBD kaufen funds average -18.3% returns, also reflecting the specific risks of this type of fund.

About CBD license

Hemp, the government allows the general public to grow, who can apply for a license to grow by themselves with the FDA on January 29.

Onwards, by planting all species, but must specify the source and specify that the output will be Sold to whom to use for what?

The inflorescence extract must contain only 0.2% THC, while the stems can be used commercially. after applying for permission will

It is considered not more than 120 days and will be able to start planting. It is expected that 3-4 months will begin to produce products to the market.

In addition, early producers of Water will benefit from the price per kg. That may be as high as 100,000 baht/kg per rai, yielding around 20-30 kg.

Leave a reply